1. Home
  2. CCCC vs AUDC Comparison

CCCC vs AUDC Comparison

Compare CCCC & AUDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCCC
  • AUDC
  • Stock Information
  • Founded
  • CCCC 2015
  • AUDC N/A
  • Country
  • CCCC United States
  • AUDC Israel
  • Employees
  • CCCC N/A
  • AUDC N/A
  • Industry
  • CCCC Biotechnology: Pharmaceutical Preparations
  • AUDC Telecommunications Equipment
  • Sector
  • CCCC Health Care
  • AUDC Utilities
  • Exchange
  • CCCC Nasdaq
  • AUDC Nasdaq
  • Market Cap
  • CCCC 304.8M
  • AUDC 304.5M
  • IPO Year
  • CCCC 2020
  • AUDC 1999
  • Fundamental
  • Price
  • CCCC $7.38
  • AUDC $11.25
  • Analyst Decision
  • CCCC Buy
  • AUDC Buy
  • Analyst Count
  • CCCC 7
  • AUDC 2
  • Target Price
  • CCCC $8.71
  • AUDC $12.00
  • AVG Volume (30 Days)
  • CCCC 2.4M
  • AUDC 99.1K
  • Earning Date
  • CCCC 08-06-2024
  • AUDC 07-30-2024
  • Dividend Yield
  • CCCC N/A
  • AUDC 3.19%
  • EPS Growth
  • CCCC N/A
  • AUDC N/A
  • EPS
  • CCCC N/A
  • AUDC 0.36
  • Revenue
  • CCCC $20,036,000.00
  • AUDC $245,246,000.00
  • Revenue This Year
  • CCCC $26.24
  • AUDC $2.14
  • Revenue Next Year
  • CCCC N/A
  • AUDC $3.74
  • P/E Ratio
  • CCCC N/A
  • AUDC $31.00
  • Revenue Growth
  • CCCC N/A
  • AUDC N/A
  • 52 Week Low
  • CCCC $1.06
  • AUDC $7.14
  • 52 Week High
  • CCCC $11.88
  • AUDC $14.45
  • Technical
  • Relative Strength Index (RSI)
  • CCCC 80.71
  • AUDC 70.83
  • Support Level
  • CCCC $4.36
  • AUDC $10.88
  • Resistance Level
  • CCCC $4.87
  • AUDC $11.22
  • Average True Range (ATR)
  • CCCC 0.48
  • AUDC 0.22
  • MACD
  • CCCC 0.32
  • AUDC 0.09
  • Stochastic Oscillator
  • CCCC 91.53
  • AUDC 90.15

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.

About AUDC AudioCodes Ltd.

AudioCodes Ltd develops and sells advanced and converged voice over IP and data networking solutions, products and applications to service providers and channels, OEMs, network equipment providers and system integrators. Its products include IP phones, session border controllers, voice applications, multi-service business routers, digital and analog media gateways, among others. The company generates revenues from the sale of products through a direct sales force and sales representatives. Its geographic segments are Israel, Americas, Europe, and the Far East. It derives a majority of the revenues from Americas segment.

Share on Social Networks: